Cargando…

Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses

Diseases caused by human herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) affect millions of people worldwide and range from fatal encephalitis in neonates and herpes keratitis to orofacial and genital herpes, among other manifestations. The viruses can be shed efficiently by asymptomatic carrie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanfield, Brent A., Kousoulas, Konstantin G., Fernandez, Agustin, Gershburg, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402837/ https://www.ncbi.nlm.nih.gov/pubmed/34452501 http://dx.doi.org/10.3390/v13081637

Ejemplares similares

Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs
por: Joyce, Jonathan D., et al.
Publicado: (2021)

Herpes Simplex Virus 2 (HSV-2) Infected Cell Proteins Are among the Most Dominant Antigens of a Live-Attenuated HSV-2 Vaccine
por: Geltz, Joshua J., et al.
Publicado: (2015)

Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2
por: Halford, William P., et al.
Publicado: (2013)

A Live-Attenuated HSV-2 ICP0 (−) Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine
por: Halford, William P., et al.
Publicado: (2011)

The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions
por: Gershburg, Svetlana, et al.
Publicado: (2015)

Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis
por: Naidu, Shan K., et al.
Publicado: (2020)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
por: Uche, Ifeanyi Kingsley, et al.
Publicado: (2021)

ICP0 Antagonizes ICP4-Dependent Silencing of the Herpes Simplex Virus ICP0 Gene
por: Liu, Mingyu, et al.
Publicado: (2010)

Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses
por: Iyer, Arun V, et al.
Publicado: (2013)

Rational Design of Live-Attenuated Vaccines against Genome-Reduced Pathogens
por: Nishikawa, Sayaka, et al.
Publicado: (2022)

Insights into the Novel Therapeutics and Vaccines against Herpes Simplex Virus
por: Malik, Shiza, et al.
Publicado: (2023)

Developments in Vaccination for Herpes Simplex Virus
por: Krishnan, Rohini, et al.
Publicado: (2021)

Predicted Structure and Functions of the Prototypic Alphaherpesvirus Herpes Simplex Virus Type-1 UL37 Tegument Protein
por: Collantes, Therese Marie A., et al.
Publicado: (2022)

Rationalizing the development of live attenuated virus vaccines
por: Lauring, Adam S., et al.
Publicado: (2010)

Live Attenuated Influenza Vaccines by Computer-Aided Rational Design
por: Mueller, Steffen, et al.
Publicado: (2010)

Principles underlying rational design of live attenuated influenza vaccines
por: Jang, Yo Han, et al.
Publicado: (2012)

The herpes simplex virus UL20 protein functions in glycoprotein K (gK) intracellular transport and virus-induced cell fusion are independent of UL20 functions in cytoplasmic virion envelopment
por: Melancon, Jeffrey M, et al.
Publicado: (2007)

Rational Development of Live-Attenuated Zika Virus Vaccines
por: Adam, Awadalkareem, et al.
Publicado: (2023)

A System for Creating Stable Cell Lines that Express a Gene of Interest from a Bidirectional and Regulatable Herpes Simplex Virus Type 1 Promoter
por: Chambers, Christopher B., et al.
Publicado: (2015)

Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines
por: Uche, Ifeanyi Kingsley, et al.
Publicado: (2022)

Understanding natural herpes simplex virus immunity to inform next-generation vaccine design
por: Sandgren, Kerrie J, et al.
Publicado: (2016)

Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2
por: Halford, William P., et al.
Publicado: (2015)

Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
por: Burn Aschner, Clare, et al.
Publicado: (2020)

Herpes Simplex and Pseudorabies Viruses
por: Hierholzer, Walter J.
Publicado: (1970)

The interaction of Herpes Simplex Virus with murine lymphocytes. I. Mitogenic properties of herpes simplex virus
Publicado: (1977)

Identification and Visualization of Functionally Important Domains and Residues in Herpes Simplex Virus Glycoprotein K(gK) Using a Combination of Phylogenetics and Protein Modeling
por: Rider, Paul J. F., et al.
Publicado: (2019)

Macrophages and cytokines in the early defence against herpes simplex virus
por: Ellermann-Eriksen, Svend
Publicado: (2005)

New strategies against drug resistance to herpes simplex virus
por: Jiang, Yu-Chen, et al.
Publicado: (2016)

Ups and downs in the search for a Herpes simplex virus vaccine
por: Bolland, Silvia, et al.
Publicado: (2015)

Immune Response to Herpes Simplex Virus Infection and Vaccine Development
por: Ike, Anthony C., et al.
Publicado: (2020)

Herpes simplex virus type-1(HSV-1) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice
por: Israyelyan, Anna, et al.
Publicado: (2008)

A Herpes Simplex Virus 1 (McKrae) Mutant Lacking the Glycoprotein K Gene Is Unable To Infect via Neuronal Axons and Egress from Neuronal Cell Bodies
por: David, Andrew T., et al.
Publicado: (2012)

Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials
por: Bernstein, David I., et al.
Publicado: (2019)

A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis
por: Uyar, Olus, et al.
Publicado: (2021)

Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma
por: Takano, Gaku, et al.
Publicado: (2020)

Emerging Highly Virulent Porcine Epidemic Diarrhea Virus: Molecular Mechanisms of Attenuation and Rational Design of Live Attenuated Vaccines
por: Hou, Yixuan, et al.
Publicado: (2019)

Intramuscular Vaccination With the HSV-1(VC2) Live-Attenuated Vaccine Strain Confers Protection Against Viral Ocular Immunopathogenesis Associated With γδT Cell Intracorneal Infiltration
por: Nabi, Rafiq, et al.
Publicado: (2021)

Herpes Simplex Virus Infection in Pregnancy
por: Straface, Gianluca, et al.
Publicado: (2012)

Photodynamic Inactivation of Herpes Simplex Viruses
por: Monjo, Andrea L.-A., et al.
Publicado: (2018)

Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1tkbiqg3psq8hj9upbeagf06aa